Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Adapted Physical Activity for adults with brain tumors

Official title: Feasibility Assessment of Adapted Physical Activity in Patients Treated for a Brain Tumor

Run by Center Eugene Marquis · NCT07570485 · Data updated 2026-11-12

We’re testing whether a supervised adapted physical activity program is feasible for adults with primary brain tumors and what adherence looks like.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment90 (estimated)
SponsorCenter Eugene Marquis
Academic / other
Locations1 site (Rennes)
StatusRecruiting
StartedJuly 8, 2026
Main results expectedJune 1, 2028
Study endsJune 1, 2028
Registry record updatedOctober 26, 2026
Trial IDNCT07570485 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18) with a primary brain tumor undergoing medical oncology treatment, able to participate in a supervised activity and with access to a smartwatch and compatible devices.

Probably not a fit

Patients uncomfortable with or unable to participate in physical activity or those lacking access to required devices may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This trial examines the feasibility of a 3-month supervised adapted physical activity program in adults with primary brain tumors. It will measure adherence, session completion, intensity and duration, and retention, as well as changes in quality of life and cancer-related symptoms using standardized questionnaires at baseline, 3 months, and 4 months. The study includes adults receiving medical oncology treatment who can participate despite possible motor, sensory, attention, or memory deficits and who have access to the required devices. Safety and feasibility outcomes will guide future larger studies.

Why it matters

Potential benefit: If feasible, APA could become a practical way to support quality of life and reduce cancer-related symptoms in brain tumor patients.

How similar studies have gone: Some previous studies in other cancer populations suggest feasibility and potential benefits of physical activity programs, but data in brain tumor patients are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Men or women ≥ 18 years old,
* Receiving medical oncology treatment at the CLCC Eugène Marquis,
* Diagnosed with a primary brain tumour, regardless of diagnosis, grade or treatment,
* Possible motor, sensory, attention, concentration, or memory deficits,
* Patients who accept the general terms of use for connected watches
* Patients affiliated with or covered by the French social security system,
* Patients who have received information and signed informed consent (or their legal representative),

Exclusion Criteria:

* WHO score ≥ 3
* Comprehension disorders that prevent participation in adapted physical activity
* Pregnant or breastfeeding women
* Patients without the necessary devices to use a smartwatch (smartphone, tablet or computer),
* Patients deprived of liberty, under guardianship, or curatorship, or subject to any other administrative safeguard measure.

Patients unable to comply with the study schedule for social, medical, or psychological reasons.

Where it's running

  • Centre Eugène Marquis
    Rennes, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Decoding Mandarin speech features from brain-surface signals

    This project will try to decode imagined Mandarin speech, including lexical tones, from high-density brain-surface (ECoG) signals in adult patients who are having clinically indicated cortical electrode placement.

    Recruiting Second Affiliated Hospital, Zhejiang University, School of Medicine · Hangzhou, Zhejiang · NCT07460037

  • Skin closure after brain tumor surgery: running absorbable versus interrupted non-absorbable sutures

    This will test whether absorbable running intradermal sutures or non-absorbable interrupted transdermal sutures produce better wound healing after craniotomy in adults with supratentorial brain tumors.

    Recruiting Medical University of Warsaw · Warsaw, Masovian Voivodeship · NCT07413796

  • Cerebrospinal fluid leak after brain tumor surgery

    This project will look at adults having planned supratentorial craniotomy for intracranial tumors to see how often cerebrospinal fluid leaks occur and what complications they cause.

    Recruiting Medical University of Warsaw · Warsaw · NCT07411690

  • B7-H3 CAR T cells for recurrent brain tumors in kids and young adults

    This early-phase trial tests a personalized CAR T-cell therapy called B7-H3 CAR T for children and young adults with recurrent or progressive brain tumors.

    Recruiting at 2 sites Phase 1 Dana-Farber Cancer Institute · Boston, Massachusetts and 1 other locations · NCT07390539

  • STRATAFIX sutures for closing cranial and spine surgical wounds

    This project will test STRATAFIX sutures for closing cranial and spine surgical wounds in adults to learn about long-term safety and healing.

    Recruiting Phase 4 University of Michigan · Lansing, Michigan · NCT07225101

  • AI-assisted diagnosis for malignant brain tumors

    This project will test an AI system that uses routine preoperative MRI scans to automatically segment and classify malignant brain tumors in adults to help guide diagnosis and care.

    Recruiting Second Affiliated Hospital, Zhejiang University, School of Medicine · Hangzhou, Zhejiang and 1 other locations · NCT07198256

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.